Scarica l'app Stockscreener
5.60
3.70%
0.20
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ARDX Giù?
Forum
Previsione
Precedente Chiudi:
$5.40
Aprire:
$5.44
Volume 24 ore:
3.31M
Relative Volume:
0.71
Capitalizzazione di mercato:
$1.35B
Reddito:
$251.85M
Utile/perdita netta:
$-72.58M
Rapporto P/E:
-17.87
EPS:
-0.3134
Flusso di cassa netto:
$-63.80M
1 W Prestazione:
+9.16%
1M Prestazione:
+24.72%
6M Prestazione:
+2.75%
1 anno Prestazione:
-3.78%
Intervallo 1D:
$5.43
$5.645
Intervallo di 1 settimana:
$5.005
$5.645
Portata 52W:
$3.21
$7.18
Ardelyx Inc Stock (ARDX) Company Profile
Nome
Ardelyx Inc
Settore
Industria
Telefono
510-745-7047
Indirizzo
34175 ARDENWOOD BLVD., FREMONT, CA
Confronta ARDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
5.60 | 1.30B | 251.85M | -72.58M | -63.80M | -0.3134 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-18 | Ripresa | H.C. Wainwright | Buy |
| 2025-05-02 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2025-03-07 | Ripresa | Ladenburg Thalmann | Buy |
| 2025-03-04 | Iniziato | BTIG Research | Buy |
| 2024-11-11 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | Iniziato | Leerink Partners | Outperform |
| 2023-12-18 | Iniziato | Raymond James | Strong Buy |
| 2023-09-07 | Iniziato | H.C. Wainwright | Buy |
| 2023-08-25 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2022-11-17 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | Downgrade | Jefferies | Buy → Hold |
| 2021-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | Downgrade | Wedbush | Outperform → Neutral |
| 2021-03-23 | Iniziato | Wedbush | Outperform |
| 2021-01-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-10-20 | Ripresa | Citigroup | Buy |
| 2020-02-18 | Ripresa | Jefferies | Buy |
| 2020-02-12 | Iniziato | Citigroup | Buy |
| 2020-02-10 | Iniziato | Cowen | Outperform |
| 2019-04-08 | Iniziato | Piper Jaffray | Overweight |
| 2018-08-24 | Iniziato | Jefferies | Buy |
| 2018-03-19 | Ripresa | Leerink Partners | Outperform |
| 2017-11-29 | Reiterato | Citigroup | Buy |
| 2017-11-22 | Reiterato | Ladenburg Thalmann | Buy |
| 2017-10-17 | Ripresa | Leerink Partners | Outperform |
| 2016-03-31 | Iniziato | Ladenburg Thalmann | Buy |
| 2016-03-09 | Iniziato | Cantor Fitzgerald | Buy |
| 2016-03-03 | Iniziato | Citigroup | Buy |
Mostra tutto
Ardelyx Inc Borsa (ARDX) Ultime notizie
Is Ardelyx Inc. exposed to currency risksFree Stock Market Entry Signals - thegnnews.com
Ardelyx (ARDX) Is Up 20.3% After Raising IBSRELA Sales Guidance and Announcing Leadership ChangesWhat's Changed - simplywall.st
Can Ardelyx’s (ARDX) Leadership Changes and Raised Guidance Reshape Its Long-Term Growth Prospects? - simplywall.st
Piper Sandler Maintains a Hold Rating on Ardelyx (ARDX) - MSN
Little Excitement Around Ardelyx, Inc.'s (NASDAQ:ARDX) Revenues As Shares Take 26% Pounding - 富途牛牛
Ardelyx Q2 Revenue Jumps 33% - AOL.com
Ardelyx raises 2025 IBSRELA revenue guidance to $250M–$260M amid sustained demand growth - MSN
Ardelyx Inc. Faces Financial Uncertainty Amid Shifting Trade Policies - The Globe and Mail
Ardelyx Inc. Q2 2025 Earnings Call Highlights - The Globe and Mail
Ardelyx price target raised to $9 from $8 at Piper Sandler - TipRanks
Insiders Of Ardelyx Are Up 20% On Their US$6.78m Purchase - 富途牛牛
Ardelyx, Inc. (NASDAQ:ARDX) Q2 2025 Earnings Call Transcript - Insider Monkey
Ardelyx Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Ardelyx Inc Faces Uncertainty Amid Shifting Trade Policies - AInvest
BTIG Remains a Buy on Ardelyx (ARDX) With a $14 PT - MSN
Ardelyx Stock Soars On Price Target Hikes After Upbeat Q2 Report: Retail Sees More Revisions Coming - MSN
Ardelyx Stock Soars On Price Target Hikes After Upbeat Q2 Report: Retail Sees More Revisions Coming By Stocktwits - Investing.com India
Ardelyx Surpasses Expectations with Remarkable Q2 Performance - timothysykes.com
Ardelyx Stock Soars: Time to Buy? - StocksToTrade
Wedbush Raises Price Target on Ardelyx to $14 From $13, Keeps Outperform Rating - MarketScreener
Ardelyx shares rise 13.21% premarket after reporting strong Q2 revenue growth and raising 2025 sales expectations. - AInvest
Ardelyx Q2 Loss Widens, Revenue Rises; Unveils Changes to Executive Team - MarketScreener
Ardelyx Inc (ARDX) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Financial ... By GuruFocus - Investing.com Canada
Ardelyx Names New CMO and CTOO, Appoints CFO - AInvest
Ardelyx Reports Strong Q2 2025 Financial Performance - TipRanks
Ardelyx's Q2 2025 Earnings Call: Key Contradictions in XPHOZAH and IBSRELA Growth Strategies - AInvest
Transcript : Ardelyx, Inc., Q2 2025 Earnings Call, Aug 04, 2025 - MarketScreener
Ardelyx (ARDX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Earnings call transcript: Ardelyx Q2 2025 beats earnings expectations By Investing.com - Investing.com UK
Earnings call transcript: Ardelyx Q2 2025 beats earnings expectations - Investing.com
Ardelyx: Q2 Earnings Snapshot - San Antonio Express-News
Ardelyx (ARDX) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Ardelyx CFO Transition Announced Amid Strong Q2 Results - TipRanks
Ardelyx Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Ardelyx Inc earnings beat by $0.05, revenue topped estimates - Investing.com
Ardelyx, Inc. Announces Executive Leadership Changes: Edward Conner, M.D. Appointed CMO and John Bishop, Ph.D. as CTOO; Justin Renz to Transition Out as CFOO - Quiver Quantitative
Biopharmaceutical firm Ardelyx's Q2 revenue rises 33% - MarketScreener
Ardelyx Announces Changes to the Executive Leadership Team - GlobeNewswire
Ardelyx Reports Second Quarter 2025 Financial Results and Provides Business Update - The Globe and Mail
Spotlight On 3 Promising Penny Stocks With Over $20M Market Cap - simplywall.st
What makes Ardelyx Inc. stock price move sharplyAccelerated profit realization - Jammu Links News
Is Ardelyx Inc. stock overvalued or undervaluedInvest confidently with professional advice - Jammu Links News
When is Ardelyx Inc. stock expected to show significant growthBoost your wealth with consistent growth stocks - Jammu Links News
Should I hold or sell Ardelyx Inc. stock in 2025Gain insights from top financial experts - Jammu Links News
Does Ardelyx Inc. stock perform well during market downturnsTrack top-performing stocks effortlessly - Jammu Links News
What is the dividend policy of Ardelyx Inc. stockIdentify undervalued stocks ready to soar - Jammu Links News
10 Best Strong Buy Penny Stocks to Buy Now - Insider Monkey
How volatile is Ardelyx Inc. stock compared to the marketBuild a portfolio that grows with the market - Jammu Links News
Is Ardelyx Inc. a good long term investmentInvest with confidence backed by data - Jammu Links News
Ardelyx Inc Azioni (ARDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.91%
3.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):